Examining Absorbed Doses of Indigenously Developed 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer Patients at Baseline and During Course of Peptide Receptor Radioligand Therapy
2019 ◽
Vol 60
(11)
◽
pp. 1579-1586
◽
2018 ◽
Vol 17
(2)
◽
pp. e875-e876
◽
2019 ◽
Vol 61
(1)
◽
pp. 62-69
◽
2020 ◽
Vol 45
(1)
◽
pp. 19-31
◽
2020 ◽